Skip to content
Fall Sale 40% off everything Ends in Offer ends November 30.

BPC-157 Research Guide: Identity, Literature, Analysis and Documentation

Research use only. StarBio products are supplied strictly for in-vitro laboratory research by qualified professionals. They are not for human or veterinary use, not for diagnostic or therapeutic use, and have not been evaluated by the FDA. This guide covers identity, documentation and handling only. It is not usage guidance.

BPC-157 is a synthetic pentadecapeptide: fifteen amino acids, no disulfide bridges, no metal, molecular weight a little over 1.4 kDa. It is one of the most requested compounds in research catalogues and one of the most discussed online, which makes accurate reference data for it more useful than usual. This page collects the identity data, the research areas the published literature covers, what to look for on its certificate, and the independent reports on file for StarBio lots.

Identity

Name BPC-157 (Body Protection Compound 157; also written BPC 157, PL 14736)
Type Synthetic pentadecapeptide
CAS number 137525-51-0
Molecular weight 1419.54 g/mol
Formula C62H98N16O22
Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Length 15 amino acids

Origin and history

The sequence is described in the literature as a fragment of a gastric juice protein, isolated and characterised by a group in Zagreb in the early 1990s and studied since then mainly in rodent models. The “body protection compound” name comes from that early work; the number 157 is the fragment designation. The cytoprotection framing that runs through much of the later literature, including a 2019 review in Gut and Liver [7], traces back to Robert’s work on gastric cytoprotection, which that review revisits.

What the literature covers

The references on file for this compound span several research areas. They are listed here as areas of study, not as results.

  • Tendon and connective tissue models. A 2011 Journal of Applied Physiology paper examined tendon fibroblast outgrowth, survival and migration in culture [2]; a 1999 rabbit study looked at a segmental bone defect model [12]; a 2025 systematic review in HSS Journal surveyed the orthopaedic and sports-medicine literature and its limitations [1].
  • Vascular signalling. Work in Scientific Reports (2020) studied vasomotor tone and the Src-Cav-1-eNOS pathway in rats [3]; a 2017 Journal of Molecular Medicine paper examined VEGFR2 activation in angiogenesis models [11].
  • Gastrointestinal and brain-gut models. Reviews in Current Neuropharmacology (2016) [6] and Neural Regeneration Research (2022) [10] summarise the gut and central nervous system literature.
  • Pharmacokinetics and preclinical safety. A 2022 Frontiers in Pharmacology study reported distribution, metabolism and excretion in rats and dogs [4]; a 2020 Regulatory Toxicology and Pharmacology paper reported a preclinical safety evaluation [5]; a Phase 1 pharmacokinetics study is registered on ClinicalTrials.gov [9].
  • Broad reviews. A 2025 review in Pharmaceuticals covers the range of models in which the peptide has been studied [8].

Most of this literature comes from a small number of groups and from animal or in-vitro models; the 2025 systematic review [1] is explicit about that, and anyone citing BPC-157 work should read its limitations section first.

Analytical notes

BPC-157 is a straightforward molecule to characterise. Reverse-phase HPLC resolves the main peak from the usual synthetic impurities (deletion and truncated sequences, incompletely deprotected species), and purity is reported as the area percentage of that peak. Identity is confirmed by mass spectrometry against the theoretical monoisotopic or average mass for C62H98N16O22. With five prolines and two aspartates in the sequence, the species most worth watching on a trace are aspartimide-related and deletion impurities, which elute close to the parent peak; a report that states the HPLC gradient and wavelength lets you judge how well those were resolved. Because the peptide is commonly supplied as an acetate or trifluoroacetate salt, HPLC purity will be higher than peptide content by weight; a measured content figure on the certificate closes that gap (see what 99% purity means).

Storage and stability

  • Lyophilized powder
  • Store at -20 °C
  • Protect from light
  • Avoid repeated freeze-thaw cycles
  • In solution: 2-8 °C, short term

Documentation for StarBio lots

Every StarBio lot is analysed by an independent laboratory. The table lists the reports on file for this compound; the Janoshik report reference can be checked against the laboratory’s own record.

Variant Laboratory / report HPLC purity Labelled / measured Tested
BPC-157 10 mg Janoshik #136388 99.70% 10 mg / 10.21 mg Apr 22, 2026 report
BPC-157 5 mg Medutest WWB-BC5-7131 98.87% 5 mg Feb 22, 2026 report

Current certificates are in the COA Library; the verify-lot form connects an order to its batch record.

References

  1. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal, 2025, PMID 40756949.
  2. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 2011, PMID 21030672.
  3. Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats. Scientific Reports, 2020, PMID 33046803.
  4. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157 in rats and dogs. Frontiers in Pharmacology, 2022, DOI 10.3389/fphar.2022.1026182.
  5. Preclinical safety evaluation of body protective compound-157. Regulatory Toxicology and Pharmacology, 2020, PMID 32334036.
  6. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Current Neuropharmacology, 2016, PMID 27138887.
  7. Stable Gastric Pentadecapeptide BPC 157, Robert’s Stomach Cytoprotection/Adaptive Cytoprotection Revisited. Gut and Liver, 2019, DOI 10.5009/gnl18490.
  8. Multifunctionality and Possible Medical Application of the BPC 157 Peptide. Pharmaceuticals (MDPI), 2025, DOI 10.3390/ph18020185.
  9. PCO-02 Safety and Pharmacokinetics Trial (Phase 1). ClinicalTrials.gov, NCT02637284.
  10. Pentadecapeptide BPC 157 and the central nervous system. Neural Regeneration Research, 2022, PMID 34380875.
  11. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine, 2017, PMID 27847966.
  12. Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits. Journal of Orthopaedic Research, 1999, PMID 10071911.

Product page: BPC-157. Related guides: what 99% purity means, how to read a certificate, storing lyophilized peptides.

For laboratory research use only. Not for human or veterinary use.

Compared with related compounds: BPC-157 vs TB-500.

Questions about BPC-157

What is BPC-157?

BPC-157 is a synthetic pentadecapeptide: 15 residues (pentadecapeptide), molecular weight 1419.54 g/mol, CAS number 137525-51-0. It is supplied for in vitro laboratory research only. This guide covers identity, documentation and handling, not use.

Is BPC-157 the same as Body Protection Compound-157, PL 14736 and Bepecin?

BPC-157 is also listed as Body Protection Compound-157, PL 14736 and Bepecin. On a certificate or vial label, the CAS number (137525-51-0) and the sequence identify the material regardless of which name is used.

What are the CAS number, formula and molecular weight of BPC-157?

BPC-157 has CAS number 137525-51-0, molecular formula C62H98N16O22 and molecular weight 1419.54 g/mol. Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Identity of each StarBio batch is confirmed by mass spectrometry on the laboratory report.

Is StarBio's BPC-157 independently tested?

Yes. The current BPC-157 batch was tested by Janoshik Analytical (Janoshik Analytical report #136388): 99.70% purity by HPLC, measured content 10.21 mg against 10 mg labelled, tested Apr 22, 2026. The report is on file in the COA library (report page). Janoshik Analytical reports can be checked on janoshik.com with the report number.

How should BPC-157 be stored?

Lyophilized powder; Store at -20 °C; Protect from light; Avoid repeated freeze-thaw cycles; In solution: 2-8 °C, short term. StarBio ships it as sealed lyophilized powder.

Where can I buy BPC-157 for laboratory research?

StarBio sells BPC-157 as 10 mg at $39.99, shipped tracked from Florida to all 50 US states. StarBio does not ship internationally. Buyers must be qualified researchers or institutions aged 21 or older, buying for in vitro laboratory work.

New reports and guides, by email

A short note when a new laboratory report is published, when a compound returns to stock, and when a new guide goes up. Nothing else. Leave whenever you like.

For laboratory research use only. No dosing or protocol content is ever sent.

StarBio

Researcher verification

StarBio supplies research compounds only to qualified researchers and laboratories, for in vitro laboratory use. Enter your date of birth and confirm your research use to continue.

You must be 21 or older.

By continuing you affirm that the date and statement above are true. Products are supplied for laboratory research only: not for human or veterinary use, not for diagnostic procedures, and not evaluated by the U.S. Food and Drug Administration. Full disclaimer.

Not a researcher? Exit